- ►annals.org J Miller, BKS Chan, HD Nelson - Annals of internal medicine, 2002 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Postmenopausal estrogen replacement is widely used in the ... Cited by 157 - Related articles - BL Direct - All 6 versions
C No - ahrq.gov AHRQ is the lead Federal agency charged with supporting research designed to
improve the quality of health care, reduce its cost, address patient safety and
medical errors, and broaden access to essential services. AHRQ sponsors and ... Related articles - View as HTML - All 4 versions
E Hoibraaten, E Qvigstad, H Arnesen, S … - THROMBOSIS AND HAEMOSTASIS-STUTTGART-, 2000 - 万方数据资源系统 Recent observational studies suggest a 2-4 fold increased risk of venous
thromboembolism (VTE) in women taking hormone replacement therapy (HRT). The
present study was started before publication of these studies, and the aim ... Cited by 206 - Related articles - BL Direct - All 4 versions
FR Rosendaal, M Vessey, A Rumley, E Daly … - British journal of haematology, 2002 - openaccess.leidenuniv.nl GD 0. LowE4 Oepartments of^Clinical Epidemiology, 2Hemostasis and Thrombosis
Research Center, Leiden Umversity Medical Center, Leiden, The Netherlands,
^Department of Public Health, Umversity of Oxford, Oxford, 4Department of ... Cited by 134 - Related articles - View as HTML - BL Direct - All 11 versions
LL Humphrey, BKS Chan, HC Sox - Annals of internal medicine, 2002 - Am Coll Physicians Data Sources: MEDLINE and Cochrane databases were searched for all primary
prevention studies reporting CVD or CAD incidence, mortality, or both in
association with HRT; reference lists, letters, editorials, and reviews ... Cited by 235 - Related articles - BL Direct - All 4 versions
- ►ucsf.edu [PDF] S Hulley, C Furberg, E Barrett-Connor, J … - Jama, 2002 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 491 - Related articles - BL Direct - All 13 versions
- ►prsjournal.com MA Shiffman - Plastic and Reconstructive Surgery, 2002 - journals.lww.com What effort does it take to require that a patient cease estrogenic hormones at
least 3 weeks before surgery and 2 weeks after surgery? If the patient refuses
to stop taking the hormones or cannot stop taking them because of the ... Cited by 3 - Related articles - BL Direct - All 7 versions
- ►ahajournals.org DM Herrington, E Vittinghoff, TD Howard, DA … - Arteriosclerosis, thrombosis, and vascular biology, 2002 - Am Heart Assoc Abstract— Oral contraceptive use in women with factor V Leiden is associated
with increased rates of venous thromboembolic events (VTEs). However, the
effects of hormone replacement therapy (HRT) in postmenopausal women with ... Cited by 122 - Related articles - BL Direct - All 9 versions
MA Shiffman - Journal of Women's Health, 2003 - liebertonline.com O RAL CONTRACEPTIVES ( ESTROGENS ) have been associated with a significant risk
of throm- boembolic disease. In fact, the Physicians' Desk Reference warns
physicians and patients about this risk when taking estrogenic hormones. ... Cited by 5 - Related articles - BL Direct - All 6 versions
A HORMONALES - semcc.com Introducción Los anticonceptivos orales (estrógenos) se asocian con riesgo
significativo de tromboembolia. El Physicians´s Desk Reference advierte a los
médicos ya los pacientes sobre este riesgo.1 “Riesgo de producir ... Related articles - View as HTML - All 2 versions
